Nika Pharmaceuticals, Inc.
NIKA
$0.41
-$0.01-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.70K | 13.40K | 37.10K | 8.00K | 18.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.70K | 13.40K | 37.10K | 8.00K | 18.40K |
| Operating Income | -19.70K | -13.40K | -37.10K | -8.00K | -18.40K |
| Income Before Tax | -19.70K | -13.40K | -37.10K | -8.00K | -18.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.70K | -13.40K | -37.10K | -8.00K | -18.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.70K | -13.40K | -37.10K | -8.00K | -18.40K |
| EBIT | -19.70K | -13.40K | -37.10K | -8.00K | -18.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.05B | 1.05B | 1.07B | 1.04B | 1.03B |
| Average Diluted Shares Outstanding | 1.05B | 1.05B | 1.07B | 1.04B | 1.03B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |